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Abstract
Expansion of the brain is one of the defining characteristics of modern humans. Seckel syndrome
(MIM210600), a disorder of markedly reduced brain and body size1,2, is associated with defective
ATR-dependant DNA damage signalling3. Previously, only a single hypomorphic mutation of
ATR has been identified in this genetically heterogeneous condition4. We now report that
mutations in pericentrin (PCNT) also cause Seckel syndrome, resulting in its loss from the
centrosome, where it has key functions anchoring both structural and regulatory proteins5,6.
Furthermore, we find that PCNT-Seckel patient cells have defects in ATR-dependent checkpoint
signalling, providing the first evidence linking a structural centrosomal protein with DNA damage
signalling. These findings also suggest that other known microcephaly genes implicated in either
DNA repair responses7 or centrosomal function8,9, may act in common developmental pathways
determining human brain and body size.
Seckel syndrome is an autosomal recessive disorder of intra-uterine growth retardation,
severe proportionate short stature and marked microcephaly1,2. The ataxia-telancgiectasia
and Rad3-related (ATR) gene is mutated in Seckel syndrome (ATR-Seckel)4, and encodes a
phosphotidylinositol-3-kinase-like kinase which has distinct, but overlapping functions with
ATM, in co-ordinating the response to DNA damage10. ATR is activated by single stranded
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DNA whilst ATM responds to DNA double strand breaks. MCPH1, encoded by another
gene whose mutations cause severe (primary) microcephaly, also acts in the ATR damage
response pathway7. Furthermore, other, non-ATR Seckel patient cell lines also exhibit
ATR-pathway dysfunction3, suggesting that mutation of further genes encoding proteins
involved in this DNA damage response cascade may cause this disorder.
To identify such components, we performed a SNP-microarray genome-wide homozygosity
scan on two consanguineous families from the Middle-East with a clinical diagnosis of
Seckel syndrome (Supplementary Fig. 1 and 2) and showing cellular evidence of defective
ATR signalling. Multipoint linkage analysis identified a novel locus, Sckl4, with a
maximum LOD score of 4.03 at 70.9cM on chromosome 21q22.3 between rs1598206 and
rs2330591 (Fig. 1 and Supplementary Fig. 2). 55 Refseq annotated genes lay within this
interval, including pericentrin (PCNT), which encodes a centrosomal protein. As several
centrosomal genes, CenpJ, ASPM and CDK5RAP2, cause the related condition, primary
microcephaly8,9, we postulated that PCNT might be the causative gene and therefore
sequenced its 47 coding exons in affected individuals from both families.
We identified a homozygous nonsense mutation in exon 4 of family 1 (E220X). A
homozygous single base-pair deletion in exon 12 in family 2 (S629fs, Fig. 1c,d) produces a
frameshift, predicted to result in premature protein truncation after an additional 65 amino
acids. Both mutations segregated with the disease in each family, with all parents being
heterozygous for the respective mutations. From screening of additional cases we identified
a further patient with a homozygous single base-pair insertion in exon 18, resulting in a
frameshift at codon 1190 (C1190fs). Neither this, nor the other two mutations were present
in over 200 control alleles screened. Collectively, these mutations disrupt all described
mammalian protein isoforms of PCNT11,12. We therefore concluded that homozygous
truncating mutations in PCNT cause Seckel syndrome.
Pericentrin (also known as kendrin) is a huge 360kDa coiled-coil protein with a C-terminal
PACT domain that targets it to the centrosome (Fig. 1d). Two protein isoforms have been
described in humans11, the full length protein, pericentrin B, and a C-terminally truncated
isoform, pericentrin A. Pericentrin localises to the pericentriolar material (PCM), where it
interacts with several structural centrosomal proteins, including γ-tubulin and PCM113,14
and is important for microtubular nucleation and spindle organisation15,16 Anti-pericentrin
antibodies disrupt mitosis, suggesting it is essential for mitotic progression15. However, its
Drosophila homolog, D-PLP, though required for timely recruitment of PCM components, is
apparently dispensible for cell division17. Furthermore, as well as its structural roles,
pericentrin acts as a scaffold to recruit signalling proteins, such as Protein Kinase A (PKA)
and Protein Kinase CβII, to the centrosome5,18.
As all mutations identified were homozygous and significantly truncated the protein, this
would suggest that they are functionally ‘null’ alleles. To test this prediction, we examined
pericentrin localisation in patient lymphoblastoid cell lines (LCLs). Centrosomal pericentrin
staining was lost in three independent LCLs, in contrast to control cell lines (Fig. 2a and
Supplementary Fig. 3), both in interphase and mitosis.
We also examined protein expression by immunoblotting (Fig. 2b). Two bands were
detected in controls (Wild-type (WT), and heterozygous relatives, PCNTE220X/+,
PCNTS629fs/+), representing two isoforms of pericentrin, which were not present in mutant
LCLs. A smaller ∼170kD band was present in PCNTE220X lymphoblastoid cells,
(potentially representing an aberrant truncated PCNT protein product), while no significant
PCNT protein was apparent in the other two mutant cell lines, therefore supporting the
molecular genetic findings that protein function is significantly, if not completely, disrupted.
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We next examined other components of the centrosome, to establish if they were affected by
the absence of pericentrin. ASPM, PCM-1, ninein and centrin were all localised normally
(Fig 2a and Supplementary Fig. 4). However, during mitosis, γ-tubulin was significantly
reduced or absent at prometaphase/metaphase (Fig 2c, d), consistent with previous RNAi
experiments6.
Other patients with Seckel syndrome are defective in the ATR DNA damage response
pathway3. We therefore assessed PCNT-Seckel patient cell lines to see if loss of this key
centrosomal protein is associated with the defects in ATR signalling previously described
for this disorder3,4. Indeed, PCNT-Seckel (PCNTC1190fs, PCNTE220X and PCNTS629fs)
LCLs exhibited defective UV-induced G2-M checkpoint arrest, similar to that seen in ATR-
Seckel patients (Fig. 3a), in contrast to cell lines established from heterozygote relatives
(PCNTE220X/+, PCNTS629fs/+) and an unrelated wild type control. This suggested that
mutations in PCNT impact on ATR-dependent cell cycle checkpoint activation. Similarly,
PCNT-Seckel LCLs also exhibited elevated nuclear fragmentation following replication fork
stalling (Fig. 3b) and supernumerary mitotic ‘centrosomes’ after prolonged mitotic arrest
with nocodazole (Fig 3c), two additional cellular phenotypes caused by impaired ATR-
signalling3.
Since, these findings suggested a direct role for PCNT in ATR-dependent DNA damage
response signalling, we examined further steps in this signalling cascade in PCNT-Seckel
cells. We found that ATR-dependent γH2AX formation was normal in Seckel-PCNT LCLs,
similar to controls (Fig 3d). This was distinct from ATR-Seckel LCLs and suggested that
ATR is able to phosphorylate a key substrate in PCNT-Seckel syndrome. Thus, Pericentrin
functions downstream of ATR kinase activation in this pathway.
We next examined hydroxyurea-induced 53BP1 foci formation in PCNT-Seckel cell lines.
Strikingly, both PCNT-Seckel and ATR-Seckel LCLs failed to form such foci in contrast to
control cell lines (Fig 3e). This phenotype is dependent on both ATR and Chk1 kinases19,
indicating that PCNT has a downstream role in ATR-pathway function.
To determine whether PCNT mutations affect other DNA damage responses, we assessed
the G2-M checkpoint response to DNA double strand breaks induced by ionising radiation.
This response is specifically dependent on ATM and not ATR signalling. PCNT-Seckel
LCLs arrested as efficiently as control LCLs under these conditions. ATR-Seckel, unlike
ATM mutant LCLs, also had a normal response, confirming the ATR-independence of this
assay (Fig 3f). Therefore, we concluded that mutations in PCNT have specific effects on the
downstream stage of the ATR-pathway including G2-M checkpoint activation.
We also performed siRNA experiments in HeLa cells to provide confirmatory evidence that
PCNT is required for ATR-dependent signalling. siRNA depletion of PCNT also results in
defective ATR-dependent (UV) checkpoint activation (Supplementary Fig. 5), as we had
observed in PCNT Seckel LCLs. Similarly, no defect was seen in ATM-dependant
checkpoint response after ionizing radiation. This substantiates our findings that PCNT
mutations cause imparied ATR signalling.
PCNT is a key structural centrosomal protein nucleating microtubular assembly during
mitosis15,16. It was thus surprising to identify homozygous truncating mutations that appear
to cause absence of known forms of the PCNT protein from centrosomes. So remarkably,
PCNT would seem to be dispensable for most aspects of human development. Pericentrin
mutations do however dramatically reduce both body and brain size by ∼ 8 standard
deviations below the norm. Other centrosomal genes (ASPM, CDK5RAP2, CENPJ) have
been implicated in determining human brain size, being mutated in primary microcephaly.
They are presumed to act through effects on neurogenic mitosis8,9,20, perhaps modulating
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symmetric/asymmetric cell division. Given PCNT's role in mitotic spindle assembly15,16,
perturbation of cell division may similarly result in globally reduced cell number, so
additionally causing reduced body size. However for ATR, MCPH1 and now PCNT genes,
there is a specific correlation between defects in ATR signalling and reduced brain and body
size4,7. This suggests an alternative explanation, that impaired ATR signalling might itself,
directly cause these phenotypes through impaired mitotic progression or reduced cell
survival.
Primary microcephaly genes have undergone significant adaptive evolution in primates,
suggesting that functional alterations in the proteins they encode may have contributed to the
evolution of human brain size21. Morphologically, Seckel syndrome also has evolutionary
parallels. Homo Floresiensis, the recently described Indonesian hominid, has similarly
marked reduced brain and body size (cranial volume -6.1 s.d, height -9.5 s.d, relative to
modern humans)22. Consequently, changes in this or similar genes could underlie the
anatomical differences seen in this hominid23.
Through study of a human disease phenotype, we have for the first time implicated a
structural protein of the centrosome in the ATR-dependent DNA damage response.
Centrosomes have a central role in regulating cell cycle progression24 and pericentrin has an
established role in recruiting regulatory proteins to the centrosome5,18. Therefore a role in
checkpoint signalling would be consistent with its known functions. Components of the
ATR-pathway have been observed to localise to the centrosome25, most notably Chk126,27.
Chk1 centrosomal localisation, mediated by activating phosphorylation at Serine317 and
345 residues28, is enhanced by DNA damage. At the centrosome, Chk1 is thought to delay
G2/M transition through inhibiting activation of Cyclin B-Cdk1 by Cdc25 27. Intriguingly,
fusion of Chk1 with a PACT domain prevents G2/M mitotic progression27, suggesting that
endogenous pericentrin, one of only two PACT domain containing proteins, could provide
the means of Chk1 localisation to mediate G2/M checkpoint arrest (model, Fig. 4).
Alternatively, PCNT may not be required for localisation of Chk1, but may be necessary for
Chk1 to transmit its signal to downstream centrosomally localized components to effect G2/
M arrest. Future investigations based on these possibilities will be valuable in understanding
the mechanism of Chk1 relocalisation and activation at the centrosome.
The identification of Pericentrin mutations in Seckel syndrome also provides an interesting
convergence between microcephaly genes implicated in ATR signalling (MCPH1, ATR)
and those involved in centrosomal function (ASPM, CDK5RAP2, CENPJ). This suggests
that further biochemical and developmental investigation is likely to be fruitful in
delineating common cellular pathways responsible for the brain and body size phenotypes in
these syndromes.
Methods
Affected individuals with Seckel syndrome
All affected individuals included in this study had a diagnosis of Seckel syndrome, having
intrauterine growth retardation, severe proportionate short stature, marked microcephaly and
developmental delay. Blood samples were obtained with informed consent from affected
children, parents and unaffected siblings. Lymphoblastoid cell lines were established by
EBV transformation and Genomic DNA extracted using standard methods. The study was
approved by the Scottish Multicentre Research Ethics Committee (04:MRE00/19), and the
University of Sussex School of Life Sciences Research Governance Committee.
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Genotyping and linkage analysis
SNP microarray genotyping was performed by AROS Applied Biotechnology (Denmark)
using Affymetrix Human Mapping 50k Xba240 Genechips. SNP genotypes were analysed
using Alohomora 29 and multipoint linkage analysis performed with GENEHUNTER
(version 2.0β) under a model of autosomal recessive inheritance with full penetrance, using
a disease allele frequency estimated at 1 in 1,000. Decode genetic map distances and
Affymetrix SNP allele frequencies were used.
Mutation detection
Primers were designed using the ExonPrimer tool in UCSC Genome Browser to amplify
coding exons of pericentrin (primer sequences listed in Supplementary Table 1). Purified
PCR amplification products were sequenced using dye-terminator chemistry and
electrophoresed on an ABI 3730 capillary sequencer (Applied Biosystems). Mutation
analysis was performed using Mutation Surveyor (Softgenetics). Anonymised control
samples were screened by sequencing.
Cell lines and cell culture
LBLs were cultured in RPMI 1640 with 15% fetal calf serum (FCS). Cells used were Wild-
type (WT; GM02188), ATR-Seckel (DK0064), Ataxia Telangiectasia-mutated (ATM;
GM03189D), all of which are described previously 4,7. PCNTE220X, (CV1559; affected
Seckel, PCNT 658G>T), PCNTE220X/+, (CV1584; unaffected brother of CV1559),
PCNTS629fs (CV1576; affected Seckel, PCNT 1887delA), PCNTS629fs/+ (CV1582;
unaffected mother of CV1576) and PCNTC1190fs (12061; affected Seckel, PCNT
3568_3569insT).
Immunofluorescence and Western Blotting
Immunostaining was performed as previously described30. Antibodies were used at the
following dilutions: pericentrin (Abcam, ab448-100) 1:1000; pericentrin (N-20) (Santa Cruz
Biotechnology) 1:100; γ-tubulin (Sigma) 1:1000; Centrin (20H5, J. Salisbury) 1: 1000;
PCM-1 (A.Merdes) 1: 1000; ASPM (Bethyl labs, IHC-00058); 1:250; Ninein (A.Merdes)
1:100. Secondary antibodies were FITC or Texas Red conjugated (Jackson Immunoresearch
lab), 1:200. Three dimensional data sets were collected with a DeltaVision system (Applied
Precision, Issaquah, WA) based on an Olympus IX-70 with a Chroma Technology Sedat
filter set driven by SoftWorx software under standard conditions. All images were archived
as raw (r3d) and deconvolved (d3d) files. Images were subjected to standard deconvolution
algorithm. Three dimensional data sets were converted to Quick Projections in SoftWorx
and then converted to TIFF files and imported into Adobe Photoshop for final presentation.
For the quantification of γ-tubulin staining in mitosis, a defined volume containing the
centrosome was used to measure the total intensity of the signal. The same volume was used
to identify the background noise as intensity outside the cells and the non-centrosomal
gamma tubulin. The ratios of centrosome-bound and dispersed gamma tubulin was averaged
for each slide after background subtraction and the relative intensity was calculated in
comparison to the WT control slide.
Immunoblotting was performed using pericentrin (Abcam, ab448-100) antibody at 1:1000,
and HRP conjugated anti-rabbit IgG secondary 1:5000 (Cell signalling 7074), detected with
ECL-Plus (Amersham).
DNA damage response assays
For ATR-dependent G2-M arrest cells were untreated (UNT) or irradiated with 5 J/m2 UV-C
(UV) and immediately seeded into complete medium, incubated for 2 hrs, before being
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cytospun onto poly-D-lysine coated slides and stained with DAPI and anti-phosphoHistone
H3 as previously described7. For the ATM-dependent G2-M arrest cells were either
untreated (UNT) or irradiated with 2 Gy ionising radiation (IR) and processed as above. For
γH2AX formation and 53BP1 foci formation, cells were either untreated (UNT) or treated
with 5 mM hydroxyurea (HU) for 2 hrs and processed for immunofluoresence (IF) staining
as previously described3. Cells were also pulse labelled (15 mins) with 50μM BrdU to allow
quantification of S-phase using anti-BrdU by IF. Supernumerary mitotic centrosomes were
determined following treatment with 1.5μM nocodazole for 24 hrs as previously described7.
Anti-γH2AX was obtained from Upstate Technology (Hampshire, UK), anti-53BP1
(BL181) from Universal Biologicals (Cambridge, UK), anti-BrdU from Autogen Bioclear
(Wiltshire, UK) and anti-γ tubulin from Sigma-Aldrich UK Ltd (Dorset, UK).
RNAi
HeLa cells were transfected with 10nmol of Invitrogen Stealth™ duplex
oligoribonucleotides using siPORT™ NeoFX™ Transfection Agent (Ambion, standard
protocol). siRNA oligo sequences, Supplementary table 1. 72 hours later G2/M checkpoint
assays were performed as outlined above.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Figure 1. Schematic of the Sckl4 critical region and the PCNT gene depicting location of
identified mutations
(a) Genetic map of chromosome 21q22.3 with the refined Sckl4 locus, defined by
overlapping homozygous chromosomal segments in two consanguineous families, and
extending over a 2.9 Mbp interval between SNP markers rs1598206 and rs2330591
(43,883,204 – 46,751,852, UCSC Browser, March 2006 Assembly). Genetic distances,
Decode genetic map. (b) PCNT spans 122kb of genomic sequence in 47 exons and encodes
a 3336 amino acid protein. (c) Sequence electropherograms of PCNT mutations. (d)
Schematic of the pericentrin protein indicating position of identified mutations and protein
structure. Pericentrin contains internal repeats (red), coiled-coil regions (green), and a PACT
domain (blue). Protein structural regions as predicted by SMART. Sites of interaction with
PKA, PKC βII and calmodulin indicated by asterisks.
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Figure 2. Pericentrin localisation and function is disrupted in PCNT-Seckel cell lines
(a) Pericentrin is not localised to the pericentiolar material in PCNT-Seckel cells.
Deconvolved immunofluorescent images from PCNT-Seckel and control lymphoblastoid
cell lines. Pericentrin (ab448-100, green) and centrin (red). Scale bar 5μm. Control,
heterozygote relative, PCNT220X/+. (b) Immunoblot of LCL cell lysates with Pericentrin
ab448-100 antibody, that detects both Pericentrin A and B isoforms. Two pericentrin
(arrowheads) isoforms are absent from PCNT-Seckel cells, but present in control
lymphoblastoid cells from heterozygous relatives. A smaller protein product of ∼170kD is
detected in the PCNT220X cell line,that might represent an aberrant truncated PCNT protein
product. Loading control, alpha-tubulin. (c,d) γ–tubulin localisation is frequently reduced or
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absent during mitosis in PCNT-Seckel cells. (c) Quantification of γ-tubulin signal in PCNT-
Seckel mitotic cells at prometaphase and metaphase, relative to wild-type. n=20. error bar,
s.d. γ-tubulin signal intensity is significantly reduced relative to wild type cells (p<0.05,
S629fs; p<0.001, E220X) (d) In PCNT-Seckel mitotic cells (astericks), γ–tubulin
centrosomal staining is reduced (arrows) or absent, relative to centrosomal staining in
adjacent interphase cells, or in control cells from a heterozygous relative.
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Figure 3. PCNT is required for ATR dependent DNA damage signalling
(a) G2-M checkpoint arrest was observed 2 h post UV treatment in control but not in ATR-
or PCNT-Seckel LCLs. The mitotic index was examined 2 hours after treatment with 5 J
m−2 UV. Average of 3 experiments, error bars, s.d. Controls:- heterozygote relatives
PCNTE220X/+ and PCNTS629fs/+ ; and an unrelated wild type (WT) control. UNT, untreated;
UV, UV-C treated. Mitotic index is significantly increased in PCNT-Seckel cells compared
with Wild-Type cells after UV treatment (p<0.001, E220X; p<0.01, S629fs; p<0.05,
C1190fs) (b) ATR- and PCNT-Seckel LCL cells have increased hydroxyurea-induced
nuclear fragmentation. Nuclear fragmentation was examined 24 h after treatment with 5mM
hydroxyurea (HU). Percentage of cells displaying nuclear fragmentation (NF) is shown
(p<0.001 WT versus PCNT-Seckel E220X) (c) ATR- and PCNT-Seckel LCL cells exhibit
elevated levels of supernumerary centrosomes in mitosis. Percentage of mitotic
(phosphohistoneH3 (Ser10) positive cells) with > 2 γ-tubulin stained foci (centrosomes)
determined following 24 h incubation with nocodazole (p<0.05 WT versus E220X) (d)
γH2AX foci formation is normal in PCNT-Seckel LCLs. Phosphorylation of the histone
H2AX (termed γH2AX) by the PI3K-kinases is one of the earliest detectable responses to
DNA damage, and is ATR-signalling specific after hydroxyurea treatment. Percentage of
γH2AX foci was determined 2 hours after treatment with 5mM hydroxyurea. (e) ATR- and
PCNT-Seckel cells show significantly reduced 53BP1 foci formation after treatment with
5mM hydroxyurea for 2 hrs, reflecting impairment in ATR/Chk1 dependent signalling.
Immunofluorescent staining with anti-BrdU confirmed that all LCLs had equivalent S-phase
populations (range: 20-23%) prior to exposure to HU (p<0.005 E220X; and p<0.001, S629fs
versus WT after HU). (f) G2-M checkpoint arrest after Ionizing Radiation (IR) is normal in
PCNT-Seckel and ATR-Seckel LCLs but not in Ataxia Telangiectasia mutated (ATM)
LCLs.
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Figure 4. Model of Pericentrin's role in ATR-dependent G2/M checkpoint arrest
Low-dose UV and Hydroxyurea activate ATR kinase which then phosphorylates
downstream targets including Chk1 kinase. Activating phosphorylation is required for
accumulation of Chk1 at the centrosome after DNA damage28. Direct or indirect binding of
Chk1 by pericentrin could mediate Chk1's localisation to the centrosome. Chk1 localisation
at the centrosome inhibits Cdc25, preventing Cyclin B/Cdk1 activation27 and thus the
transition from G2 in to mitosis.
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